Sernova Biotherapeutics Inc SVA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CA$0.11
- Day Range
- CA$0.12–0.12
- 52-Week Range
- CA$0.09–0.20
- Bid/Ask
- CA$0.12 / CA$0.12
- Shares Outstanding
- 377.64M
- Market Cap
- CA$43.43M
- Volume/Avg
- 14,100 / 224,455
Key Statistics
- Price/Earnings (Normalized)
- 6.91
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 8
- Website
- https://www.sernova.com
Valuation
|
Metric
|
SVA
|
|---|---|
Price/Earnings (Normalized) | 6.91 |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
SVA
Financial Strength
|
Metric
|
SVA
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.03 |
Interest Coverage | −6.48 |
Quick Ratio
SVA
Profitability
|
Metric
|
SVA
|
|---|---|
Return on Assets (Normalized) | −894.82% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
SVA
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|?Kz&SsX | LOCK|mZ$%> | $123B | |||
| Moderna Inc
MRNA
| LOCK|Y@&>l?? | LOCK|jYb | $86B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|xCf%Wm | LOCK|@&$t! | $78B | |||
| argenx SE ADR
ARGX
| LOCK|stk&m@n | LOCK|f?N | $50B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|@pB!<^ | LOCK|B& | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|%<t@S$ | LOCK|&kt^! | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|<>%KJNZW | LOCK|?$Fv | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|yJ#GvJh | LOCK|!&< | $22B | |||
| Incyte Corp
INCY
| LOCK|Qf$Fvd | LOCK|Jvw | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|Xp$<HgX | LOCK|mF | $14B |
United States